A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway

Grant

Awarded By

Total Award Amount

  • 434474.00

    • Direct Costs

  • 343843.00

    • Sponsor Award Id

  • R21AI157362

    • Contributor

  • Christina Ochsenbauer   Investigator  
  • John Kappes Ph.D.   Investigator  
  • Robert Reynolds Ph.D.   Principal Investigator